ArticleFrontiers in digital health2025
Clinical experience with remote programming of cardiac implantable electronic devices.
Article in Frontiers in digital health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: As remote monitoring has become the standard of care for follow-up of cardiac implantable cardiac devices, extensions of remote monitoring can provide greater efficiency for the patient, caregiver, and industry representatives. To accomplish greater efficiency and flexibility of remote monitoring, and as an interim step toward "true" remote monitoring, LiveSupport was introduced as an innovative programmer and software solution that allows for remote programming of all current and most legacy BIOTRONIK devices. Objective: To determine the utilization and efficacy of LiveSupport as an extension of remote monitoring and the level of satisfaction with this modality. Methods Analysis of the USA dataset of LiveSupport utilization from 04/01/2022 to 04/30/2025 was completed. In addition, satisfaction with LiveSupport was assessed with a total of 159 surveys of patients, remote caregivers, and industry representative. Results: A total of 38,943 total LiveSupport sessions, from 2831 unique Renamic Neo Programmers, and 555 unique users were successfully completed. LiveSupport utilization increased substantially over time, peaking at 2,295 sessions per month. Survey results were consistent with high levels of satisfaction for patients, remote caregivers, and industry representatives. It was estimated that LiveSupport saved more than 60 min per patient in 78% of the sessions. Conclusion: LiveSupport as an extension of remote monitoring is safe and effective with marked advantages for patients, remote caregivers, and industry representatives. This technical solution is an important step toward "true" remote monitoring of cardiac electronic implantable devices.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.